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Both leprosy and tuberculosis were prevalent in Europe during the first millenium but thereafter 
leprosy declined. It is not known why this occurred, but one suggestion is that cross-immunity 
protected tuberculosis patients from leprosy. In order to investigate any relationship between the 
two diseases, selected archaeological samples, dating from the Roman period to the 13th century,  
were examined for both Mycobacterium leprae and Mycobacterium tuberculosis DNA, using 
PCR. The work was carried out and verified in  geographically separate and independent 
laboratories. Several specimens with palaeopathological signs of leprosy were found to contain 
DNA from both pathogens, indicating that these diseases co-existed in the past. We suggest that 
the immunological changes found in multi-bacilliary leprosy, in association with the socio-
economic impact on those suffering from the disease, led to increased mortality from 
tuberculosis and therefore to the historical decline in leprosy. 
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1. INTRODUCTION 
Tuberculosis and leprosy (Hansen's disease) have long been known to occur in antiquity 
(Lechat 1999; Rothschild et al. 2001) as they leave readily identifiable bony changes on skeletal 
remains (Møller-Christensen 1961, pp 42-43; Buikstra 1981). Tuberculosis has remained at 
epidemic levels since the onset of industrialisation in Europe and is of increasing importance in 
modern medicine, with an estimated one third of the world's population infected (Kochi 1991) 
and more than 8.2 million new cases in the year 2000 (Corbett et al. 2003). Approximately 90% 
of those infected show no immediate symptoms due to the activity of the cell-mediated immune 
response. The current high mortality levels are primarily due to co-infection with HIV and the 
associated immuno-suppression (Rose et al. 2002).  
Leprosy is rarely found today in Western Europe but it is still a significant disease 
worldwide, with more than half a million cases detected in 2002, most in south-east Asia 
(http://www.who.int/lep/stat2002/global02.htm). Leprosy is primarily a disease of peripheral 
nerves and skin but also affects bones. Its clinical effects vary from the slowly developing pauci-
bacillary or tuberculoid leprosy, to the  multi-bacillary lepromatous leprosy. In this lepromatous 
state there is direct invasion of soft tissues around the face and mouth by Mycobacterium leprae 
(Andersen & Manchester 1992; Roberts & Manchester 1995). The type of infection is dependent 
on the immune response of the host. Leprosy  apparently ravaged the Middle East and Europe 
from biblical times until the late medieval period, although diagnoses based only on written 
reports remain questionable. One of the effects of leprosy, particularly due to the fear it 
engendered in antiquity, is that these individuals would become isolated and therefore be more 
likely to suffer from poor nurtrition and a weakening of the immune system, thereby  paving the 
way for opportunistic co-infection or the resurgence of a latent infection. 
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There have been a number of proponents of the theory that the decline of leprosy in 
Western Europe, from its fearsome prevalence in the 12-13th centuries to its virtual absence by 
the 16th Century (Roberts & Manchester 1997), was due to the increasing prevalence of 
tuberculosis. A mathematical model of the epidemiology of leprosy and tuberculosis suggests 
that tuberculosis could have contributed to the historical  decline of leprosy if  the basic 
reproductive rate of leprosy was low (Lietman et al. 1993).  There is significant evidence that a 
level of cross immunity exists between the two bacteria  (Murhekar et al. 1995; Ohara et al. 
2000; Roche et al., 2001) and this led to the suggestion that this protected individuals with a 
latent tuberculosis infection from acquiring leprosy (Chaussinard 1948; Fine 1984).  Another 
theory is that leprosy patients became more susceptible to underlying latent tuberculosis due to 
the decline in immune status associated with the progression of the disease. 
DNA from the causative organisms, Mycobacterium tuberculosis and M. leprae, can be 
detected by species-specific PCR, and the initial reports (Spigelman & Lemma 1993; Rafi et al. 
1994) have been confirmed by many investigators, reviewed by Spigelman and Donoghue 
(2003). Both pathogens have no known environmental reservoir, so their presence indicates 
infection, if not active disease. 
The aim of this study was to investigate any relationship between M.leprae and M. 
tuberculosis infections in human archaeological remains by using species-specific PCR to detect 
the DNA of these organisms. Specimens containing M.leprae DNA, and showing clear signs of 
the pathology associated with multi-bacillary leprosy, were examined for the presence of 
M.tuberculosis DNA. Specimens known to contain M.tuberculosis DNA were examined for 
M.leprae DNA. Subsequently a small number of previously unstudied specimens were examined 
for evidence of both organisms. 
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2.   MATERIALS AND METHODS 
(a)  Samples. 
The skeletal material for this study came from a variety of sources. Laboratory 1 (UCL) 
examined samples from all sites. Laboratory 2 (Thunder Bay/Jerusalem) examined samples from 
Israel and Egypt: 
1.  Cavum nasale samples from three skeletons from graves 11, 222 and 503 in a 10th 
century site at Püspökladány, Hungary. The remains from graves 222 and 503 showed 
pathological changes consistent with multi-bacillary leprosy (Donoghue et al. 2002). The 
skeleton from grave 11 showed only periostitis inside the maxilla. 
2.  Material was obtained from five skeletons from a leprosy hospital (according to 
contemporary documentary evidence), dating from the 15th century and located at Szombathely, 
Hungary. There were no morphological changes on the bones and the cause of death was stated 
as the plague. Samples were taken from the cavum nasale and maxilla.  
3.  Also from Hungary, samples were obtained from three skeletons buried by the 11th-16th 
century Basilica at  Székesfehérvár. Two 11th century skeletons (79a and 89) showed typical 
leprotic morphological alterations around the nasal cavity. Skeleton 89 also showed marked 
evidence of an abscess on the tibia. The third skeleton, from the 14th-16th century (I/II), showed 
severe periostitis on both tibias but no specific pathology. 
4.  Archaeological remains from a 1st century A.D family tomb in Akeldama, the Hinnom 
Valley, Israel (Gibson et al. 2002) were analysed. One individual was wrapped in a shroud and 
placed in a loculus sealed with plaster. A fragmented phalanx with an advanced pathological 
lesion was discovered from the chest region. The differential diagnosis included tuberculosis. 
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Fragmented skull and other skeletal elements from the shroud loculus individual were examined, 
together with the pulp of a molar tooth. In addition skeletal material, with no pathological 
evidence of lesions, from two infants from a wall niche was studied.  
5.  Specimens from the Dakhleh Oasis, Egypt (Molto 2002), dating from the Roman period, 
were examined. All the skeletal samples examined from this site had evidence of pathological 
lesions. Two young adult male burials, B6 and B116, had pathology strongly suggestive of 
multi-bacillary leprosy. Samples from two other young adult males, B9 and B222, had possible 
leprosy pathology. Remaining samples showed early skeletal changes consistent with a number 
of diseases, including leprosy and tuberculosis. 
6.  Material was obtained from a small medieval cemetery at Björned, in northern Sweden 
dating from the Viking period, the late 10th century to the late 13th century (Nuorala et al., 
2004). Five adult individuals were selected at random. Metacarpals (2), coxae (1) and patella (2) 
were examined. There were no specific indications of infectious disease. 
 
(b) DNA extraction 
The recommended protocols of ancient DNA (aDNA) work (O'Rourke et al., 2000) were 
followed, with  separate rooms for different stages of the process. The procedures have been 
described previously (Rothschild et al., 2001; Spigelman et al., 2002).  In brief, approximately 
25 mg of powdered sample was demineralised in Proteinase K/EDTA  at 56oC for 24-72 hours. 
In Laboratory 1 samples were split and one aliquot incubated at 56oC for one hour with 0.1M N-
phenacylthiazolium bromide (PTB), a reagent that cleaves glucose-derived protein cross-links 
(Poinar et al., 1998). Thereafter both aliquots were lysed in guanidium thiocyanate solution and 
DNA captured onto silica in suspension or by using a spin filter. After washing and drying, DNA 
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was eluted from the silica, aliquoted and used immediately or stored at -20oC. Negative 
extraction controls were always included. All extractions and analyses were repeated. 
 
(c) DNA amplification 
Details have been described previously (table 1). The M.tuberculosis complex was 
detected by targeting a specific region of the repetitive element IS6110. In Laboratory 1 a two-
tube nested PCR was used which yielded an outer product of 123 bp and  a nested PCR product 
of 92 bp (Rothschild et al., 2001; Spigelman et al., 2002). In some cases 1M betaine was 
included in the PCR mix as a facilitator. Laboratory 2 used a larger target sequence of 246 bp. 
M.leprae was detected  by amplification of the repetitive RLEP fragment, using nested PCR 
which resulted in an outer product of 129 bp and a 99 bp nested product (Donoghue et al., 2001, 
2002). Negative controls were always included.  
 
(d)  Detection and sequencing 
PCR product was detected by staining with ethidium bromide and visualising under 
ultraviolet light. In London sequencing was carried out by MWG-BIOTECH AG (Ebersberg, 
Germany). Elsewhere, sequencing was carried out in-house according to published protocols 
(Spigelman et al. 2002). 
 
3. RESULTS 
Negative DNA extraction and PCR controls were satisfactory. Twentyfour of the 32 
samples examined contained amplifiable DNA  for one or other of these pathogens (table 2), 
both of which were found at all six sites. M.tuberculosis complex-specific DNA was detected in 
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18 samples and M.leprae-specific DNA was found in 16 samples. Ten samples contained  DNA 
from both organisms (figure 1). The four sites with co-infected samples were from Roman 
Egypt, 1st century Palestine, 10th century Hungary and Mediaeval Sweden. Results from 
different laboratories showed some slight discrepancies but each obtained evidence of co-
infection. When both forward and reverse strands were sequenced the consensus sequences were 
in complete agreement with those in the NCBI database for the target regions. Where only a 
single DNA strand was sequenced there were minor discrepancies. 
 
4. DISCUSSION 
 DNA from both M. leprae and M. tuberculosis was detected, sometimes in the same 
samples, in spite of their age and the different local environmental conditions in which they were 
found. Approximately 30% of specimens examined, with differing degrees of bone 
palaeopathology, and 40% of those with DNA from one of these organisms, were harbouring 
both pathogens. It is believed that only 3-5% of tuberculosis infections result in bony lesions 
(Resnick & Niwayama 1995), so it is not surprising that some specimens, with little or no 
pathology, were positive for M. tuberculosis DNA. There is likely to be uneven distribution of 
the microbial pathogens within the sample, which could explain some of the minor discrepancies 
found between the different laboratories that examined this material. In addition, there were 
slight differences in techniques, including quantity of sample examined and PCR primers used, 
that may also have contributed (Spigelman et al., 2002). 
The presence of DNA from M.leprae and the M.tuberculosis complex indicates infection, 
as these pathogens have no known environmental reservoir. The samples were obtained from 
bone, which indicates disseminated, therefore active disease. The demonstration of the presence 
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of both pathogens in a specimen demonstrates that these diseases co-existed in the past, which is 
supported by palaeopathology  (Manchester 1991).  An examination of the literature reveals 
previous reports of  leprosy and tuberculosis co-infections. In 1895, in the early days of medical 
bacteriology, Hansen noted that tuberculosis was a major cause of death in his leprosy patients in 
Oslo. He wrote that "The most frequent complication which we have seen in our institutions is 
tuberculosis, particularly some years ago, for then the institutions were over-crowded, and 
subsequently the sanitary conditions were in many respects unsatisfactory" (Hansen, 1895).  This 
monograph continues with lengthy tables outlining the symptoms and pathology of patients 
suffering from both diseases.  
In modern times it was noted that up to 26% of  patient with M. leprae infections had 
concomitant tuberculosis infections diagnosed during the life of the patient (Nigam et al., 1979; 
Kumar et al., 1982; Rafi and Feval 1995) and at post-mortem (Jayalakshmi et al., 1985; Glaziou 
et al., 1993). In French Polynesia, Glaziou and co-workers examined the records of more than 
1000 leprosy patients who had been in institutions between 1902 and 1991. They found that 
between 1902 and 1930, before the onset of effective antimicrobial therapy, mortality from 
tuberculosis in these leprosy patients was 21%. It appeared that more multi-bacillary patients 
died of tuberculosis (13%) than paucibacillary patients (4%), although in many instances there 
were insufficient details to distinguish between the clinical forms of the leprosy infection.  
Co-infection by two or more organisms is not uncommon. Generally, one organism 
weakens the patient and reduces the ability of the immune system to respond adequately or 
rapidly enough and this allows a more virulent organism to infect the patient. In multi-bacillary  
(lepromatous) leprosy, patients show an impaired cell-mediated response to M.leprae, which is 
believed to be associated with HLA type (Abel et al., 1998). It may also be linked to a genetic 
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defect (Kang & Chae 2001) found in a significant proportion of the population (22%). The defect 
is in toll-like receptor 2 (TLR2), a protein that apparently  plays a vital role in triggering host 
defence mechanisms against microbial invasion (Krutzik & Modlin 2003). This area is still under 
active research, but it appears likely that an impaired cell-mediated response would allow the 
great predator, M.tuberculosis, to advance.  Indeed, an  examination of the incidence of leprosy 
and tuberculosis in Texas from 1938-1980 indicated that the number of cases of both diseases 
increased or decreased in tandem (Wilbur et al. 2001), although the clinical forms of leprosy 
were not distinguished.  
 It should not be forgotten that individuals suffering from leprosy often suffer social 
isolation and stigma (Bainson & van den Borne 1998), especially in the past (Cule 2002).  This 
can lead to physical and mental stress that has an adverse effect on resistance to infectious 
diseases. One of the populations sampled in the present study, the Dakhleh Oasis, is known to 
have suffered from cribra orbitalia, an indicator of anaemic stress (Fairgrieve & Molto, 2000). 
The authors include in their speculation on the possible causes of this condition, synergism 
between disease and poor nutrition. Iron is an essential nutrient for pathogenic mycobacteria and 
the host response of mild anaemia is beneficial to the patient (Ratledge 2004). However, with 
disseminated infections the severe anaemic stress found in the Dakhleh population is likely to 
have exacerbated both diseases. It has been suggested that the Dakhleh Oasis was used as a place 
for the isolation of those suffering from leprosy (Dzierzykray-Rogalski 1980), which may 
explain the readily-detectable presence there of  both leprosy and tuberculosis.  
In conclusion, the cross-immunity hypothesis appears unlikely because of the evidence of 
disseminated infection in the present study.  We believe that the reduction in an effective cell-
mediated immune response associated with multi-bacillary leprosy, coupled with the social 
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impact of the disease, would lead to re-activation of an underlying latent tuberculosis infection, 
or to superinfection with M.tuberculosis, and to a speedier death.  In time this would decrease the 
number of individuals suffering from leprosy, leading to the observed phenomenon of its decline. 
 
Dr Shimon Gibson of the Israeli Antiquities Authority facilitated our access to the Shroud Cave samples 
and we appreciate his support. 
 
REFERENCES 
Abel, L., Sanchez, F. O., Oberti, J., Thuc, N. V., Hoa, L. V., Lap, V. D., Skamene, E., Lagrange, 
P. H. &  Schurr, E.  1998 Susceptibility to leprosy is linked to the human NRAMP1 gene.  J. 
Infect. Dis. 177, 133-145. 
Andersen, J. G. &  Manchester K. 1992 The rhinomaxillary syndrome in leprosy:a clinical 
radiological and paleopathological study. Int. J. Osteoarchaeol.  2, 121-129. 
Bainson, K. A. & Van den Borne, B. 1998 Dimensions and process of stigmatization in leprosy. 
Lepr. Rev.  69, 341-350.  
Buikstra, J. E. (ed.). 1981 Prehistoric tuberculosis in the Americas. Northwestern University 
Archeological Program, Evanston, Illinois. 
Chaussinand, R. 1948 Tuberculose et lèpre, maladies antagoniques. Eviction de la lèpre parl la 
tuberculose. Int. J. Lepr. 16, 431-438. 
Corbett, E., Watt C. J., Walker, N., Maher, D., Williams, B. G., Raviglione, M. C. &  Dye, C.  
2003 The growing burden of tuberculosis: global trends and interactions with the HIV 
epidemic. Arch. Intern. Med.  163, 1009-1021. 
Cule, J. 2002  The stigma of leprosy: its historical origins and consequences with particular 
reference to the laws of Wales. In The past and present of leprosy (ed. C.A. Roberts, M.E. 
 12 
Lewis & K. Manchester), pp 149-154.  Oxford: British Archaeology Reports,  BAR 
International series 1054, Archaeopress. 
Donoghue, H. D., Gladkowska-Rzeczycka. J., Marcsik. A., Holton. J. &  Spigelman, M. 2002 
Mycobacterium leprae in archaeological specimens. In The past and present of leprosy (ed. 
C. A. Roberts, M. E. Lewis &  K. Manchester), pp 271-285.  Oxford: British Archaeology 
Reports,  BAR International series 1054, Archaeopress. 
Donoghue, H. D., Holton, J. & Spigelman, M. 2001 PCR primers that can detect low levels of 
Mycobacterium leprae DNA. J. Med. Microbiol. 50, 177-182. 
Dzierzykray-Rogalski, T. 1980 Paleopathology of the Ptolemaic inhabitants of Dakhleh Oasis. J 
Hum. Evol. 9, 71-74. 
Fairgrieve, S. I. &  Molto, J. E.  2000 Cribra orbitalia in two temporally disjunct population 
samples from the Dakhleh Oasis, Egypt.  Am. J. Phys. Anthropol. 111, 319-331. 
Fine, P. 1984 Leprosy and tuberculosis--an epidemiological comparison. Tubercle 65, 137-153. 
Gibson, S., Greenblatt, C., Spigelman, M., Gorski,A., Donoghue, H. D., Vernon, K. & Matheson, 
C. D. 2002 The Shroud Cave - a unique case study linking a closed loculus, a shroud and 
ancient mycobacteria. Ancient Biomolecules 4, 134. 
Glaziou, P., Cartel, J. L., Moulia-Pelat, J. P., Ngoc, L. N. &  Chanteau, S. 1993 Tuberculosis in 
leprosy patients detected between 1902 and 1991 in French Polynesia. Int. J. Lepr. Other 
Mycobact. Dis. 61, 199-204  
Hansen, G. A. &  Looft, C. 1895, reprinted 1973  Leprosy: in its clinical and pathological 
aspects. Bristol: John Wright & Co. 
Jayalakshmi, P., Looi, L. M., Lim, K. J., Rajogopalan, K. 1987 Autopsy findings in 35 cases of 
leprosy in Malaysia. Int. J. Lepr. Other Mycobact. Dis. 55, 510-514. 
 13 
Kang, T. J. &  Chae, G. T.  2001 Detection of Toll-like receptor 2 (TLR2) mutation in the 
lepromatous leprosy patients.  FEMS Immunol. Med. Microbiol.  31, 53-58. 
Kochi, A. 1991 The global tuberculosis situation and the new control strategy of the World 
Health Organisation. Tubercle 72, 1-6. 
Krutzik, S. R. &  Modlin, R. L. 2004 The role of Toll-like receptors in combating mycobacteria. 
Semin. Immunol. 16, 35-41. 
Kumar, B., Kaur, S., Kataria, S. &  Roy, S. N. 1982 Concomitant occurrence of leprosy and 
tuberculosis--a clinical, bacteriological and radiological evaluation. Lepr. India 54, 671-676. 
Lechat, M. F. 1999 The paleopathology of leprosy: an overview. Int. J. Lepr. Other Mycobact. 
Dis. 67, 460-470. 
Lietman, T., Porco, T. &  Blower, S. 1993 Leprosy and tuberculosis: the epidemiological 
consequences of cross-immunity. Int. J. Lepr. Other Mycobact. Dis.  61, 199-204. 
Manchester, K. 1991 Tuberculosis and leprosy: evidence for interaction of disease. In Human 
paleopathology:current syntheses and future options (ed D. C. Ortner & A. C. Aufderheide), 
pp. 23-35.  Washington DC: Smithsonian Institution Press. 
Møller-Christensen, V. 1961.  Bone Changes in Leprosy. Copenhagen, Munksgaard.  
Molto, J. E. 2002 Leprosy in Roman period skeletons from Kellis 2, Dakhleh, Egypt.  In  The 
past and present of leprosy (ed. C. A. Roberts, M. E. Lewis & K. Manchester), pp 179-192.  
Oxford: British Archaeology Reports,  BAR International series 1054, Archaeopress. 
Murhekar, M.V., Kulkarni, H.R., Zodpey, S.P. &  Dehankar, A.G. 1995 Effectiveness of mass 
neonatal BCG vaccination in the prevention of pulmonary tuberculosis: a case-control study 
in Nagpur, India. Tuber. Lung Dis. 76, 545-549. 
 14 
Nigam, P., Dubey, A. L., Dayal, S. G., Goyal, B. M., Saxena, H.N. & Samuel, K. C. 1979 The 
association of leprosy and pulmonary tuberculosis. Lepr. India 51, 65-73. 
Nuorala, E., Donoghue, H. D., Spigelman, M., Götherström, A., Hårding, B., Grundberg, L., 
Alexandersen, V., Leden, I. & Lidén, K. 2004. Diet and disease in Björned, a Viking-Early 
Medieval site in Northern Sweden. Paper II, Molecular Palaeopathology. Ancient DNA 
analyses of the bacterial diseases tuberculosis and leprosy. In: Theses and Papers in 
Scientific Archaeology 6. Stockholm: Archaeological Research Laboratory, Stockholm 
University. 
Ohara, N., Matsuoka, M., Nomaguchi, H., Naito, M. &  Yamada, T. 2000 Inhibition of 
multiplication of Mycobacterium leprae in mouse foot pads by recombinant Bacillus 
Catmette-Guerin (BCG). Vaccine 18, 1294-1297. 
O'Rourke, D. H., Hayes, M. G. & Carlyle, S. W. 2000 Ancient DNA studies in physical 
anthropology. Annu. Rev. Anthropol. 29, 217-242. 
Poinar, H. N., Hofreiter, M., Spaulding, W. G., Martin, P. S., Stankiewicz, B. A., Bland, H., 
Evershed, R. P., Possnert, G. &  Pääbo, S. 1998. Molecular coproscopy: dung and diet of the 
extinct Ground Sloth Nothrotheriops shastensis. Science 281, 402-406. 
Rafi ,A. &  Feval, F. 1995 PCR to detect Mycobacterium tuberculosis DNA in sputum samples 
from treated leprosy patients with putative tuberculosis. Southeast Asian J. Trop. Med. 
Public Health  26, 253-257. 
Rafi, A., Spigelman, M., Stanford, J., Lemma, E., Donoghue, H. &  Zias, J. 1994 DNA of 
Mycobacterium leprae  detected by PCR in ancient bone. Int. J. Osteoarchaeol. 4, 287-290. 
Ratledge, C.  2004 Iron, mycobacteria and tuberculosis. Tuberculosis (Edinb).  84, 110-130. 
 15 
Resnick, D. & Niwayama, G. 1995. Osteomyelitis, septic arthritis and soft tissue infections: 
organisms. In Diagnosis of bone and joint disorders (ed. D. Resnick), pp 2448-2558. 
Edinburgh: W. B. Saunders. 
Roberts, C. &  Manchester, K. 1995  The Archaeology of Disease. Cornell University Press, 
Ithaca, NY. 
Roche, P. W., Neupane, K. D., Failbus, S. S., Kamath, A. &  Britton, W.J. 2001 Vaccination 
with DNA of the Mycobacterium tuberculosis 85B antigen protects mouse foot pad against 
infection with M. leprae. Int. J. Lepr. Other Mycobact. Dis. 69, 93-98. 
Rose, A. M. C., Sinka, K., Watson, J. M., Mortimer, J. Y. &  Charlett, A. 2002 An estimate of 
the contribution of HIV infection to the recent rise in tuberculosis in England and Wales. 
Thorax  57, 442-445. 
Rothschild, B. M., Martin, L. D., Lev, G., Bercovier, H., Bar-Gal, G., Greenblatt, C., Donoghue, 
H., Spigelman, M. &  Brittain, D. 2001 Mycobacterium-tuberculosis complex DNA from an 
extinct bison dated 17,000 years before the present. Clin. Infect. Dis. 33, 305-311. 
Spigelman, M. &  Donoghue, H. D. 2003 Paleobacteriologywith special reference to pathogenic 
mycobacteria. In Emerging pathogens: archaeology, ecology and evolution of infectious 
disease (ed C. Greenblatt & M. Spigelman M.), pp 175-188.  Oxford: Oxford University 
Press. 
Spigelman, M. &  Lemma, E. 1993 The use of the polymerase chain reaction (PCR) to detect 
Mycobacterium tuberculosis in ancient skeletons. Int. J. Osteoarchaeol. 3, 137-413. 
Spigelman, M., Matheson, C., Lev, G., Greenblatt, C. &  Donoghue, H.D. 2002 Confirmation of the 
presence of Mycobacterium tuberculosis complex-specific DNA in three archaeological 
specimens. Int. J. Osteoarchaeol. 12, 393-400. 
 16 
Wilbur, A. K., Buikstra, J. E. &  Stajanowski, C. 2002. Mycobacterial disease in North America: 
an epidemiological test of Chaussinand’s cross-immunity hypothesis. In  The past and 
present of leprosy (ed. C. A. Roberts, M. E. Lewis & K. Manchester), pp 247-258.  Oxford: 
British Archaeology Reports,  BAR International series 1054, Archaeopress. 
World Health Organisation. Global Leprosy Situation in 2003. Available at 
http//:www.who.int./lep/stat2002/global02.htm 
 
 
 
 
 
 17 
 
Table 1. Primers used in this study 
Name  Target region  Target size  Primer 
M.tuberculosis complex-specific primers 
Laboratory 1 
P1  IS6110   123 bp  5’CTCGTCCAGCGCCGCTTCGG 3’ 
P2      "     5’CCTGCGAGCGTAGGCGTCGG 3’ 
IS-3      "   92 bp  5' TTCGGACCACCAGCACCTAA 3' 
IS-4      "     5' TCGGTGACAAAGGCCACGTA 3' 
Laboratory 2 
INS-1   IS6110   246 bp  5' CGTGAGGGCATCGAGGTGGC 3'  
INS-2      "     5' GACGTAGGCGTCGGTGACAAA 3'  
 
M.leprae-specific primers 
Laboratory 1 and 2 
LP1  RLEP   129 bp  5'TGCATGTCATGGCCTTGAGG3’ 
LP2      "     5'CACCGATACCAGCGGCAGAA3’ 
LP3      "   99 bp  5'TGAGGTGTCGGCGTGGTC3’ 
LP4      "     5'CAGAAATGGTGCAAGGGA3’ 
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Table 2. Distribution of M.leprae and M.tuberculosis complex-specific DNA according to 
specimen source and age 
( + positive; - negative; n/a not applicable) 
Sample site Sample  M.leprae M.tuberculosis  Co-infection 
10th century 
Hungary 
Püspökladény1 
11 + - - 
222 + + + 
503 + + + 
429 + - - 
621 - - n/a 
Szombathely1 
15th century 
Hungary  
6 - + - 
10 + - - 
3, 19, 20 - - n/a 
Székesfehérvár1 
11th century & 
C14-16th 
79a - - n/a 
89 + - - 
I/II - + - 
1st century Israel 
Akeldama2, 
Himmon valley 
BSC - + - 
BCN - + - 
C1 + + + 
SCP - + - 
 
 
4th century 
Egypt 
The Dakhleh 
Oasis2 
 
B6 + +3 + 
B9 - +4 - 
B116 + - - 
B222 +5 +3 + 
B251 + +6 + 
B265 +3 + + 
B2807 + + + 
B377 - + - 
B392 + +3 + 
B437 +5 - - 
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Björned1 
10-13th century 
Sweden 
A4 + + + 
A25 - + - 
A1a, 2, 8 - - n/a 
Total 32 16 18 10/24 
 
1Examined by Laboratory 1 only 
2Examined by Laboratories 1 and 2 
3Positive in Laboratory 1 only 
4Positive in Laboratory 1 when an alternative Taq polymerase was used. Positive in Laboratory 2 
using standard technique 
5Positive in Laboratory 2 only 
6Positive in Laboratory 1 when PTB used in DNA extraction. Positive in Laboratory 2 using 
standard technique 
7Examined by Laboratory 2 only 
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 Figure 1. Gel electrophoresis analysis of (top row)  MTB IS6110 PCR products (92 bp) 
and  (bottom row) M.leprae RLEP PCR products (99 bp). Lane 1: Shroud cave sample 
BSC*, DNA extract a; lane 2: Shroud cave sample C1, DNA extract a; lane 3: 
Püspökladány sample 222, DNA extract b; lane 4: Dakhleh Oasis sample B6, DNA extract 
b; lane 5: Dakleh Oasis sample B116, DNA extract b; lane 6: Shroud cave sample BSC, 
DNA extract b; lane 7: Shroud cave sample C1, DNA extract b; lane 8; negative control, 
extraction a;  lane 9: negative control, extraction b; lane 10: PCR negative control; lane 11: 
ØX174HaeIII molecular markers. *In other extractions this sample was positive for 
IS6110. 
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Lanes 
 
 
 
 
 
 
 
 
 
      1      2      3      4      5      6     7      8      9    10     11   
 
         92 bp 
 
 
     99 bp 
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